The TORC1/TORC2 inhibitor, Palomid 529, reduces tumor growth and sensitizes to docetaxel and cisplatin in aggressive and hormone-refractory prostate cancer cells. (Q39546457)
Jump to navigation
Jump to search
scientific article published on July 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The TORC1/TORC2 inhibitor, Palomid 529, reduces tumor growth and sensitizes to docetaxel and cisplatin in aggressive and hormone-refractory prostate cancer cells. |
scientific article published on July 2011 |
Statements
The TORC1/TORC2 inhibitor, Palomid 529, reduces tumor growth and sensitizes to docetaxel and cisplatin in aggressive and hormone-refractory prostate cancer cells (English)
Foteini Petini
David Sherris
Vincenzo Tombolini
Claudio Festuccia